Services | ABNewswire

Spring Is Here – and Toronto’s Trees Need Attention

Tree Doctors Inc. certified arborists serving the Greater Toronto Area – professional tree care since 1970. As winter ends, Toronto’s trees may be hiding serious damage — and homeowners don’t know it yet. Tree Doctors Inc., a GTA-based certified arborist … Continue reading →

The Prime Cleaner Ranked Top-Rated for Post-Construction Cleaning in Miami

The Prime Cleaner’s post-construction cleaning team has completed cleaning for five newly built Coral Gables estates valued between $40 million and $85 million. Miami’s The Prime Cleaner has earned top-rated status for post-construction cleaning after four years of serving luxury … Continue reading →

Specialty Concrete Coatings Publishes Commercial Floor Coating Evaluation Guide for Pittsburgh and Northwestern Pennsylvania Facilities

A logo of Specialty Concrete Coatings Specialty Concrete Coatings has released a free contractor evaluation guide for business owners and facility managers across Greater Pittsburgh and NW Pennsylvania. The resource details the risks of underqualified installations — inadequate surface preparation … Continue reading →

Autistic Disorder Pipeline Expands with 25+ Companies and 25+ Therapies in Development Across Clinical Stages, Reveals DelveInsight

Autistic Disorder Pipeline Key Autistic Disorder companies include AbbVie, Yamo Pharmaceuticals, Stalicla SA, Vanda Pharmaceuticals, Paxmedica, SciSparc, Scioto Biosciences, Hoffmann-La Roche, ACADIA Pharmaceuticals Inc., Neurotech International, Neuren Pharmaceuticals, MapLight Therapeutics, Jazz Pharmaceuticals, Axial Therapeutics Inc., and several others. DelveInsight’s “Autistic … Continue reading →

Atopic Dermatitis Pipeline Expands with 120+ Therapies and 100+ Companies Advancing Novel Treatments, Reveals DelveInsight Report

Atopic Dermatitis Pipeline Atopic Dermatitis companies including Pfizer, Kymera Therapeutics, BenevolentAI, AstraZeneca, Qurient, Sterna Biologicals, Vanda Pharmaceuticals, and Arcutis Biotherapeutics, among others are actively developing treatment options for atopic dermatitis. The “Atopic Dermatitis Pipeline Insight, 2026” report by DelveInsight presents … Continue reading →

Autosomal Dominant Polycystic Kidney Disease Market Set for Robust Growth by 2034 Amid Advancing Therapeutics Landscape | DelveInsight

The dynamics of the autosomal dominant polycystic kidney disease market are anticipated to change in the coming years, owing to the launch of emerging therapies such as XRx-008 (Xortx Therapeutics), CYX082 (Novartis), AZD1613 (AstraZeneca), VX-407 (Vertex Pharmaceuticals), ABBV-CLS-628 (Calico Life … Continue reading →

CT-388 Comprehensive Forecast on the Accelerating Market Growth for Obesity and Type 2 Diabetes Mellitus by 2034

[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on CT-388 providing insights into the drug market landscape and market forecast of CT-388 upto 2034. Are you interested in finding out the … Continue reading →

Chronic Lymphocytic Leukemia Clinical Trial Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline landscape. It covers the Chronic Lymphocytic Leukemia pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Cholangiocarcinoma Clinical Trial Pipeline Shows Potential with Active Contributions from 55+ Key Companies | DelveInsight

DelveInsight’s, “Cholangiocarcinoma Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cholangiocarcinoma pipeline therapeutics … Continue reading →

Advanced Renal Cell Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Renal Cell Carcinoma Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the Advanced Renal Cell Carcinoma Pipeline drug profiles, including clinical and nonclinical … Continue reading →

Thursday - March 12, 2026

Category Archives: Services